Weekly curated updates on drug launches, global approvals, and pharma R&D developments
January 17, 2026
Weekly Pharma Update: NEXPLANON Extension & Biosimilars
FDA Approves Extended-Use NEXPLANON® Implant What’s new: The U.S. Food and Drug Administration (FDA) approv...
Read Full StoryJanuary 10, 2026
Weekly Pharma Update: Oral GLP-1 Launch & Deals
1) Novo Nordisk Begins U.S. Launch of Oral Wegovy® Weight-Loss Pill What’s new: Novo Nordisk has **official...
Read Full StoryDecember 27, 2025
Weekly Pharma Update – 15th to 27th December 2025
1) FDA Approves Lunsumio VELO™ for Subcutaneous Use in Follicular Lymphoma Date: 22 December 2025 What’s...
Read Full StoryDecember 13, 2025
Weekly Pharma Update — 8 to 13 December 2025
1) FDA Approves DAYBUE® STIX for Rett Syndrome (12 Dec 2025) What’s new: The U.S. FDA has given the green l...
Read Full Story